Centiva Capital’s Verona Pharma VRNA Stock Holding History

Centiva Capital’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,017	Closed	-$382K	–	2127
2025 Q1	$382K	Buy	+6,017	New	+$360K	0.02%	957
2024 Q4	–	Sell	-10,262	Closed	-$295K	–	2477
2024 Q3	$295K	Sell	10,262 -6,135	-37%	-$151K	0.01%	1588
2024 Q2	$237K	Buy	16,397 +4,242	+35%	+$61.9K	0.01%	1595
2024 Q1	$196K	Buy	+12,155	New	+$210K	0.01%	1485

Other funds holding VRNA

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Summit Partners Public Asset Management Boston, Massachusetts $2.16B AUM 162.29% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return